Chassany O - Search Results

1

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C. Guyonnet D, et al. Among authors: chassany o. Aliment Pharmacol Ther. 2007 Aug 1;26(3):475-86. doi: 10.1111/j.1365-2036.2007.03362.x. Aliment Pharmacol Ther. 2007. PMID: 17635382 Clinical Trial.

2

Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease.

Chassany O, Le-Jeunne P, Duracinsky M, Schwalm MS, Mathieu M. Chassany O, et al. Value Health. 2006 Jan-Feb;9(1):39-46. doi: 10.1111/j.1524-4733.2006.00079.x. Value Health. 2006. PMID: 16441523

3

Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study.

Chassany O, Bonaz B, Bruley DES Varannes S, Bueno L, Cargill G, Coffin B, Ducrotté P, Grangé V. Chassany O, et al. Aliment Pharmacol Ther. 2007 May 1;25(9):1115-23. doi: 10.1111/j.1365-2036.2007.03296.x. Aliment Pharmacol Ther. 2007. PMID: 17439513 Free PMC article. Clinical Trial.

4

Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.

Le Cleach L, Chassany O, Levy A, Wolkenstein P, Chosidow O. Le Cleach L, et al. Among authors: chassany o. Dermatology. 2008;216(1):46-55. doi: 10.1159/000109358. Dermatology. 2008. PMID: 18032899

5

Probiotics and the irritable bowel syndrome.

Chassany O, Matuchansky C. Chassany O, et al. Aliment Pharmacol Ther. 2008 Apr 1;27(7):616-7; author reply 617-8. doi: 10.1111/j.1365-2036.2008.03617.x. Epub 2008 Jan 14. Aliment Pharmacol Ther. 2008. PMID: 18194493 No abstract available.

6

Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA) questionnaire: development and psychometric validation.

Guyonnet D, Chassany O, Picard C, Guillemin I, Meunier J, Seignobos E, Vigneux M, Lassel T, Trudeau E. Guyonnet D, et al. Among authors: chassany o. Public Health Nutr. 2008 Nov;11(11):1163-72. doi: 10.1017/S1368980008001729. Epub 2008 Feb 18. Public Health Nutr. 2008. PMID: 18279564

7

Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease.

Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K. Chassany O, et al. Aliment Pharmacol Ther. 2008 Jun 1;27(11):1053-70. doi: 10.1111/j.1365-2036.2008.03683.x. Epub 2008 Mar 20. Aliment Pharmacol Ther. 2008. PMID: 18363898 Review.

8

Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?

Chassany O, Duracinsky M. Chassany O, et al. Aliment Pharmacol Ther. 2008 Aug 1;28(3):371-2. doi: 10.1111/j.1365-2036.2008.03704.x. Aliment Pharmacol Ther. 2008. PMID: 18638076 No abstract available.

9

Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?

Chassany O, Duracinsky M. Chassany O, et al. Aliment Pharmacol Ther. 2008 Aug 1;28(3):371-2; author reply 372-3. Aliment Pharmacol Ther. 2008. PMID: 19086238 No abstract available.

10

International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease.

Holtmann G, Chassany O, Devault KR, Schmitt H, Gebauer U, Doerfler H, Malagelada JR. Holtmann G, et al. Among authors: chassany o. Aliment Pharmacol Ther. 2009 Mar 15;29(6):615-25. doi: 10.1111/j.1365-2036.2008.03922.x. Epub 2008 Dec 19. Aliment Pharmacol Ther. 2009. PMID: 19183145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results